$16.60
$0.00 (0.00%)
End-of-day quote: 05/24/2024
NYSE:TEVA

Teva Pharmaceutical Industries Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$15.85B $14.93B $15.88B $16.66B $16.89B $18.27B $21.85B $21.90B $19.65B $20.27B $20.31B $20.32B $18.31B $16.12B $13.90B $11.09B $9.41B $8.41B $5.25B $4.80B
GM % Gross Margin %
48.25% 46.72% 47.83% 46.38% 44.63% 45.41% 48.89% 54.95% 57.79% 54.54% 52.75% 52.74% 53.88% 56.89% 55.18% 53.88% 51.84% 50.65% 47.24% 46.95%
OM Operating Margin
20.07% 17.84% 19.39% 18.34% 16.08% 16.20% 18.21% 22.47% 25.61% 22.03% 19.54% 21.04% 23.82% 27.22% 24.23% 24.14% 25.46% 26.07% 24.99% 25.40%
EPS Earnings Per Share
$0.00 $2.56 $2.52 $2.58 $2.57 $2.40 $2.92 $4.01 $5.14 $5.42 $5.07 $5.01 $5.35 $4.97 $4.08 $3.37 $2.86 $2.38 $2.30 $1.59 $1.42
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.51 $1.36 $1.36 $1.36 $1.31 $1.08 $0.95 $0.78 $0.64 $0.50 $0.35 $0.31 $0.34 $0.20
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.72% 26.46% 25.09% 26.82% 26.15% 20.19% 19.11% 19.12% 18.99% 17.48% 14.71% 13.48% 21.38% 14.08%
Sha. Shares
1121.09m 1110.9m 1103.33m 1096.51m 1092.19m 1089.39m 1,017m 1,015m 908m 852m 848m 857m 883m 898m 885m 851m 768m 758m 619m 611.4m
OCF Operating Cash Flow
$1.37B $1.59B $798.00M $1.22B $748.00M $2.45B $2.23B $3.89B $5.54B $5.13B $3.24B $4.57B $4.13B $4.14B $3.37B $3.23B $1.81B $2.06B $1.37B $1.25B
FCF Free Cash Flow
$2.39B $1.04B $236.00M $638.00M $2.05B $3.68B $2.70B $4.32B $4.77B $4.20B $2.21B $2.61B $3.08B $3.43B $2.65B $2.55B $1.27B $1.67B $1.06B $935.00M
FCFS Free Cash Flow Per Share
$0.75 $0.94 $0.21 $0.58 $0.16 $1.75 $1.07 $2.86 $5.58 $4.92 $2.60 $3.98 $3.46 $3.82 $3.04 $3.27 $1.65 $2.21 $1.72 $1.53